Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Operating Expenses | 167 | 85 | 68 | 2 | 4 |
| Operating Income | -167 | -85 | -68 | -2 | -4 |
| Other Income | -547 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -714 | -85 | -68 | -2 | -4 |
| Net Income Continuous | -714 | -85 | -68 | -2 | -4 |
| Net Income | $-714 | $-85 | $-68 | $-2 | $-4 |
| EPS Basic Total Ops | -1.00 | 0.00 | 0.00 | N/A | 0.00 |
| EPS Basic Continuous Ops | -0.99 | -0.12 | -0.15 | -0.03 | 0.00 |
| EPS Diluted Total Ops | -1.00 | 0.00 | 0.00 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -0.99 | -0.12 | -0.15 | -0.03 | 0.00 |
| EBITDA(a) | $-165 | $-85 | $-68 | $-2 | $-3 |